Company Filing History:
3 out of 1,942 
1 out of 1 
1 out of 5,463 
Years Active: 2021-2024
Title: Innovations and Contributions of Inventor Yongrong Zhang
Introduction
Yongrong Zhang is a notable inventor based in Columbia, MD (US), recognized for his significant contributions to the field of biotechnology. With a total of three patents to his name, Zhang has focused on developing innovative solutions for treating infections caused by Clostridium difficile.
Latest Patents
Zhang's latest patents include groundbreaking methods and compositions aimed at combating Clostridium difficile toxins. One of his patents describes protein inhibitors of Clostridium difficile toxin B, detailing a method for treating or preventing infections through the administration of an antitoxin. This antitoxin may include a designed ankyrin repeat protein (DARPin), which can be monomeric or dimeric for effective neutralization of toxin B. Another significant patent involves a humanized tetra-specific octavalent antibody against both Clostridium difficile toxins A and B. This patent outlines novel antibody-based binding agents derived from camelid VH and human immunoglobulins, which exhibit specificity and neutralizing activity against these toxins, providing potential treatment options for primary and recurrent Clostridium difficile infections.
Career Highlights
Throughout his career, Yongrong Zhang has worked with esteemed organizations, including the University System of Maryland and Fzata, Inc. His work has significantly advanced the understanding and treatment of Clostridium difficile infections, showcasing his dedication to improving public health through innovative research.
Collaborations
Zhang has collaborated with notable colleagues, including Hanping Feng and Zhiyong Yang, contributing to the development of his patented technologies and enhancing the impact of his research.
Conclusion
Yongrong Zhang's innovative work in developing treatments for Clostridium difficile infections highlights his role as a leading inventor in biotechnology. His patents reflect a commitment to addressing critical health challenges through scientific advancement.